Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cirrhosis； Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03139058
What this trial is testing

Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Liver FibrosesLiver CirrhosesSquamous Cell Carcinoma of the Head and Neck
Centre Hospitalier Universitaire, Amiens 2
Not applicableLooking for participantsNCT06778317
What this trial is testing

MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis

Who this might be right for
Hepatocellular Carcinoma (HCC)CirrhosisRisk Prediction for Liver Cancer+1 more
Central Hospital, Nancy, France 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827
What this trial is testing

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University 36
Not applicableLooking for participantsNCT06265272
What this trial is testing

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

Who this might be right for
Liver CirrhosisHepatic Cell CarcinomaPortal Hypertension
Massachusetts General Hospital 45
Not applicableStudy completedNCT06583161
What this trial is testing

Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)

Who this might be right for
Myocardial InfarctionIschemic StrokeAngina Pectoris+12 more
Harvard School of Public Health (HSPH) 503,325
Not applicableStudy completedNCT01532427
What this trial is testing

ALFApump System Post Marketing Surveillance Registry

Who this might be right for
Liver CirrhosisRefractory AscitesMalignant Ascites
Sequana Medical N.V. 100
Not applicableStudy completedNCT03318380
What this trial is testing

Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 612
Large-scale testing (Phase 3)Study completedNCT00502086
What this trial is testing

Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.

Who this might be right for
CirrhosisChronic Hepatitis C
Catalysis SL 100
Not applicableNot Yet RecruitingNCT07097870
What this trial is testing

Predictors of HCC in Post-HCV Cirrhotic Patients After SVR

Who this might be right for
HCC - Hepatocellular Carcinoma
Sohag University 400
Early research (Phase 1)Study completedNCT02204930
What this trial is testing

PeproStat Haemostat Study in Subjects Undergoing Liver Surgery

Who this might be right for
Hemorrhage
Haemostatix Ltd 20
Not applicableStudy completedNCT02958592
What this trial is testing

Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study

Who this might be right for
Liver TumorHepatic Fibrosis
Sun Yat-sen University 121
Not applicableActive Not RecruitingNCT05165446
What this trial is testing

Novel MRE Technique to Assess a Risk Factor for Liver Cancer

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Natalie Torok 35
Not applicableActive Not RecruitingNCT06366425
What this trial is testing

Screening for Chronic Liver Diseases in General Population

Who this might be right for
Fibrosis, Liver
University Hospital, Montpellier 260
Not applicableWithdrawnNCT02899325
What this trial is testing

FDGal PET/CT to Detect Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Liver Disease
British Columbia Cancer Agency
Early research (Phase 1)UnknownNCT03278925
What this trial is testing

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

Who this might be right for
Cirrhosis
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06648525
What this trial is testing

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Harbin Medical University 68
Large-scale testing (Phase 3)Study completedNCT02984124
What this trial is testing

Communication During Hospitalization About Resuscitation Trial

Who this might be right for
Severe Life-limiting COPDSevere Life-limiting Heart FailureSevere Life-limiting Cirrhosis+3 more
University of Vermont 182
Not applicableUnknownNCT05800561
What this trial is testing

Prognostic Role of HVPG and ICG-R15 in the Short- and Medium-term Results of the Surgery of HCC on Cirrhosis

Who this might be right for
Hepatocellular Carcinoma
Federico II University 208
Not applicableStudy completedNCT03311152
What this trial is testing

Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Central Hospital, Nancy, France 639
Not applicableLooking for participantsNCT06212635
What this trial is testing

Hemostasis in Liver Cirrhosis and Hepatocellular Cancer

Who this might be right for
Hemostasis in Decompensated Liver CirrhosisInflammation in Decompensated Liver Cirrhosis
Region Stockholm 100
Next Page